BackMenlo Therapeutics Overview

Menlo Therapeutics Receivables

Latest receivables for MNLO: $11M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$11.19M

Peer trimmed avg / median

Loading

Menlo Therapeutics Receivables History

Loading

Menlo Therapeutics vs. peers: Receivables Comparison

Loading

Menlo Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Menlo Therapeutics (MNLO) FAQ

As of the most recent data (September 2020), MNLO shows a receivables of $11M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MNLO's receivables is now $11M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Menlo Therapeutics is outperforming or lagging.

Tracking MNLO's receivables over time shows whether Menlo Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $11M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Menlo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $11M) with ownership activity and broader fundamentals.

Menlo Therapeutics's receivables is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.